Cosette Pharmaceuticals
As of the edition of 20 October 2026, Cosette Pharmaceuticals runs 13 drugs, 13 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 13 |
| Total | 13 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Methotrexate | none listed | 2 |
| Acetaminophen | none listed | 17 |
| Ketorolac | none listed | 6 |
| Diclofenac | none listed | 7 |
| Prasugrel | none listed | 0 |
| Indomethacin | none listed | 3 |
| Zolpidem | none listed | 0 |
| Olmesartan medoxomil | none listed | 1 |
| Colesevelam | none listed | 0 |
| Clobazam | none listed | 0 |
| Bremelanotide | none listed | 0 |
| Cevimeline | none listed | 0 |
| Tolazamide | none listed | 0 |
A route B row is one company at one target.